首页> 外文期刊>Scientific reports. >A generic standard additions based method to determine endogenous analyte concentrations by immunoassays to overcome complex biological matrix interference
【24h】

A generic standard additions based method to determine endogenous analyte concentrations by immunoassays to overcome complex biological matrix interference

机译:一种基于通用标准加法的方法,可以通过免疫测定法克服复杂的生物基质干扰,从而确定内源性分析物的浓度

获取原文
           

摘要

We describe a novel generic method to derive the unknown endogenous concentrations of analyte within complex biological matrices (e.g. serum or plasma) based upon the relationship between the immunoassay signal response of a biological test sample spiked with known analyte concentrations and the log transformed estimated total concentration. If the estimated total analyte concentration is correct, a portion of the sigmoid on a log-log plot is very close to linear, allowing the unknown endogenous concentration to be estimated using a numerical method. This approach obviates conventional relative quantification using an internal standard curve and need for calibrant diluent, and takes into account the individual matrix interference on the immunoassay by spiking the test sample itself. This technique is based on standard additions for chemical analytes. Unknown endogenous analyte concentrations within even 2-fold diluted human plasma may be determined reliably using as few as four reaction wells.
机译:我们描述了一种新的通用方法,该方法基于掺有已知分析物浓度的生物测试样品的免疫测定信号响应与对数转换后的估计总浓度之间的关系,得出复杂生物基质(例如血清或血浆)中未知内源浓度的分析物。如果估算的总分析物浓度是正确的,则对数对数图上的乙状结肠部分非常接近线性,从而可以使用数值方法估算未知的内源性浓度。这种方法消除了使用内标曲线的常规相对定量,并且不需要校准稀释剂,并且通过添加测试样品本身,考虑了各个基质对免疫测定的干扰。该技术基于化学分析物的标准添加。即使使用2倍稀释的人血浆,也可以可靠地确定甚至稀释2倍的人类血浆中的未知内源分析物浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号